Webinars - Oncology
Ralph McDade, PhD from Myriad RBM presented a triphase approach to biomarker pattern discovery for cancer immunotherapy and autoimmune disease at the inaugural Powering Precision Health Summit 2016.
Use of Simoa Planar Protein Multiplex Arrays as a Sensitive Biomarker Platform in Oncology Clinical Trials
Wednesday, December 12, 2018 8AM PST | 11AM EST | 4PM GMT | 5PM CET
John Yan, PhD, from Takeda Pharmaceutical Company presented an ultrasensitive assay format for detecting PD biomarkers in cell and xenograft tumors at the inaugural Powering Precision Health Summit 2016.
This webinar describes a groundbreaking new technique published recently in Analytical Chemistry for measuring single cancer cells. The study, conducted by Dr. David Walt and his research group at Tufts University, demonstrates that the ultrasensitive Simoa technology makes it possible to quantify…
Speaker: Dan Sikkema, PhD, Vice President Biomarker Services, Quanterix Moderator: Dr. Jayshan Carpen, Moderator, Nature Research